Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 656 across all filing types
Latest filing 2019-11-18 Board/Management Inform…
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
Barbro Fridén avgår som styrelseledamot i Vitrolife AB (publ)
Board/Management Information Classification · 100% confidence The document is a press release dated November 18, 2019, announcing that Barbro Fridén is resigning as a board member ('styrelseledamot') of Vitrolife AB. This directly concerns a change in the company's board of directors or senior management. According to the definitions, this aligns perfectly with the 'Board/Management Information' category (Code: MANG). The document is short and is an announcement, not a comprehensive report.
2019-11-18 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'delårsrapport januari-september 2019' (Interim Report January-September 2019) for Vitrolife AB. It contains comprehensive financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on performance for the third quarter and the first nine months of the year. It is a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report. 9M 2019
2019-11-06 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'interim report january-SEPTEMBER 2019' and contains comprehensive financial data, including income statements, balance sheet summaries, segment reporting, and CEO commentary for the specified period. It is a substantive financial report covering a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-11-06 English
Valberedning i Vitrolife AB (publ)
AGM Information Classification · 99% confidence The document is a press release dated October 7, 2019, announcing the members appointed to the Nomination Committee (Valberedning) for the upcoming Annual General Meeting (AGM) in 2020. It also mentions the date of the AGM (April 28, 2020) and the procedure for submitting agenda items. Since the core content relates to the preparation and composition of the committee responsible for nominating directors and setting up the AGM, it falls under the scope of AGM-related information, specifically the preparatory materials or announcements leading up to the meeting, rather than the final voting results (DVA) or the proxy solicitation materials (PSI). Given the options, AGM-R (AGM Information) is the most appropriate fit for materials directly concerning the composition and setup for the Annual General Meeting.
2019-10-07 Swedish
Election committee for Vitrolife AB (publ)
Board/Management Information Classification · 99% confidence The document explicitly discusses the appointment of members to the 'election committee for the Annual General Meeting in 2020' and mentions the date of the upcoming AGM. This content directly relates to the preparatory materials and governance surrounding the Annual General Meeting. Therefore, it fits the definition of AGM Information (AGM-R). The document length is short (2369 chars), but the content is substantive regarding AGM committee appointments, not just an announcement of a report's publication.
2019-10-07 English
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document explicitly details a change in shareholding for 'William Demant Fonden' in 'Vitrolife AB', showing the 'Before the transaction' and 'After the transaction' share quantities and resulting percentages. The section header 'Reason for major shareholding notification Buy' confirms the nature of the filing. This directly corresponds to the definition of a Major Shareholding Notification, which is classified as 'MRQ'. The document length (4270 chars) is substantial enough to be the report itself, not just an announcement of a report.
2019-10-04 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.